Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain
the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in
Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles
and JavaScript.
With a strong foundation in neuroscience and clinical research, Shanghai is investing heavily to spearhead brain research, and forming a comprehensive network.
Combining clinical and basic research strengths, the Institutes of Brain Science (IOBS) at Fudan University in Shanghai has pioneered neuroscience innovation set to bring significant social benefit.
Immunologists have developed two drug candidates that block an important inflammation pathway, leading to promising trials that could one day help treat conditions such as inflammatory bowel and cardiovascular disease, arthritis, and Alzheimer’s.
The medical hub’s research into a single-dose vaccine for the lethal Middle East respiratory syndrome coronavirus (MERS-CoV) is promising, but more evaluation and trials are needed, scientists say.
Zooming in on gastrointestinal microbiota, a team in Shanghai has developed safe, evidence-based, innovative therapies for digestive disorders and other diseases.
A new centre in Taiwan is dedicated to strengthening global connections for Taiwan’s research community, and has made remarkable impact with its diverse activities.
A Taiwanese university leading in engineering is leveraging its assets to define new interdisciplinary research areas for future growth, featuring biotechnology.
Integrating a wide research reach, a young university in Taiwan has leveraged its medical science strengths to make substantial academic and social impacts.